FDA Inspection 1249100 — Maine General Medical Center
The FDA completed an inspection of Maine General Medical Center on August 29, 2024 in Augusta, ME. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 29, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Augusta, ME (United States)